IMMUNOCORE HOLDINGS PLC - AMERICAN DEPOSITARY SHAR

Immunocore announces upcoming presentation and posters at ASCO 2024

24 Apr 2024 10:00:00 By Nasdaq GlobeNewswire

Immunocore to present at upcoming investor conferences

04 Apr 2024 16:00:00 By Nasdaq GlobeNewswire

Immunocore presented two posters at CROI 2024

05 Mar 2024 16:30:00 By Nasdaq GlobeNewswire

Immunocore to present at upcoming investor conferences

01 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Immunocore reports fourth quarter and full year 2023 financial results and provides a business update

28 Feb 2024 07:34:03 By Nasdaq GlobeNewswire

Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial

22 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024

21 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Immunocore Prices Upsized Convertible Senior Notes Offering

30 Jan 2024 23:30:00 By Nasdaq GlobeNewswire

Immunocore Announces Proposed Convertible Senior Notes Offering

29 Jan 2024 16:05:00 By Nasdaq GlobeNewswire

Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation

05 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference

03 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update

07 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023

01 Nov 2023 16:01:00 By Nasdaq GlobeNewswire

Immunocore to present at upcoming investor conferences

30 Oct 2023 16:30:00 By Nasdaq GlobeNewswire

Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial

21 Oct 2023 08:45:00 By Nasdaq GlobeNewswire

Immunocore announces upcoming presentation and posters at ESMO 2023

06 Oct 2023 07:01:00 By Nasdaq GlobeNewswire

Immunocore to present at upcoming investor conferences

11 Sep 2023 17:00:00 By Nasdaq GlobeNewswire

Immunocore to present at upcoming investor conferences

01 Sep 2023 16:00:00 By Nasdaq GlobeNewswire

Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update

10 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

Immunocore to report second quarter 2023 financial results and host call on August 10, 2023

03 Aug 2023 08:00:00 By Nasdaq GlobeNewswire